Lv22
118 积分 2023-09-08 加入
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
11小时前
已完结
Large-Scale Amidations in Process Chemistry: Practical Considerations for Reagent Selection and Reaction Execution
29天前
已完结
Direct deaminative functionalization with N-nitroamines
1个月前
已完结
Formation of Dialkyl-N-nitrosamines in Aqueous Solution: An Experimental Validation of a Conservative Predictive Model and a Comparison of the Rates of Dialkyl and Trialkylamine Nitrosation
2个月前
已完结
A Consideration of the Extent That Tertiary Amines Can Form N-Nitroso Dialkylamines in Pharmaceutical Products
2个月前
已完结
Reactivities of N-Nitrosamines against Common Reagents and Reaction Conditions
3个月前
已完结
Stereocontrolled First Generation Synthesis of RIPK1 Inhibitor GDC-8264
4个月前
已完结
Discovery of RMC-6291, a potent, orally bioavailable, covalent RAS(ON) G12C selective inhibitor
5个月前
已完结
Synthetic Approaches and Clinical Application of KRAS Inhibitors for Cancer Therapy
5个月前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
5个月前
已完结
皖公网安备34019202002308
